Placzek EA et al. |
Mechanisms for recycling and biosynthesis of endogenous cannabinoids anandamide and 2-arachidonylglycerol. |
2008 |
J. Neurochem. |
pmid:18778304
|
Avraham Y et al. |
2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist, in various rat tissues during the evolution of experimental cholestatic liver disease. |
2008 Jul-Aug |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:18771906
|
Placzek EA et al. |
Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown. |
2008 |
Neuropharmacology |
pmid:18760289
|
Nomura DK et al. |
Monoacylglycerol lipase regulates 2-arachidonoylglycerol action and arachidonic acid levels. |
2008 |
Bioorg. Med. Chem. Lett. |
pmid:18752948
|
Burston JJ et al. |
N-arachidonyl maleimide potentiates the pharmacological and biochemical effects of the endocannabinoid 2-arachidonylglycerol through inhibition of monoacylglycerol lipase. |
2008 |
J. Pharmacol. Exp. Ther. |
pmid:18682568
|
Fowler CJ and Ghafouri N |
Does the hydrolysis of 2-arachidonoylglycerol regulate its cellular uptake? |
2008 |
Pharmacol. Res. |
pmid:18675915
|
Ellgren M et al. |
Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects. |
2008 |
Eur Neuropsychopharmacol |
pmid:18674887
|
Llorente R et al. |
Gender-dependent cellular and biochemical effects of maternal deprivation on the hippocampus of neonatal rats: a possible role for the endocannabinoid system. |
2008 |
Dev Neurobiol |
pmid:18666205
|
Hoover HS et al. |
Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling. |
2008 |
Bioorg. Med. Chem. Lett. |
pmid:18657971
|
Baldassarri S et al. |
The endocannabinoid 2-arachidonoylglycerol activates human platelets through non-CB1/CB2 receptors. |
2008 |
J. Thromb. Haemost. |
pmid:18647220
|
Njie YF et al. |
Aqueous humor outflow effects of 2-arachidonylglycerol. |
2008 |
Exp. Eye Res. |
pmid:18597752
|
Rockwell CE et al. |
A COX-2 metabolite of the endogenous cannabinoid, 2-arachidonyl glycerol, mediates suppression of IL-2 secretion in activated Jurkat T cells. |
2008 |
Biochem. Pharmacol. |
pmid:18571623
|
Endsley MP et al. |
Expression and function of fatty acid amide hydrolase in prostate cancer. |
2008 |
Int. J. Cancer |
pmid:18566995
|
Motaghedi R and McGraw TE |
The CB1 endocannabinoid system modulates adipocyte insulin sensitivity. |
2008 |
Obesity (Silver Spring) |
pmid:18551116
|
Qin N et al. |
TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons. |
2008 |
J. Neurosci. |
pmid:18550765
|
Palmer JA et al. |
Fatty acid amide hydrolase inhibition enhances the anti-allodynic actions of endocannabinoids in a model of acute pain adapted for the mouse. |
2008 |
Neuroscience |
pmid:18541380
|
Nabemoto M et al. |
Release of arachidonic acid by 2-arachidonoyl glycerol and HU210 in PC12 cells; roles of Src, phospholipase C and cytosolic phospholipase A(2)alpha. |
2008 |
Eur. J. Pharmacol. |
pmid:18539271
|
Di Filippo M et al. |
Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis. |
2008 |
J. Neurol. Neurosurg. Psychiatr. |
pmid:18535023
|
Zhang J and Chen C |
Endocannabinoid 2-arachidonoylglycerol protects neurons by limiting COX-2 elevation. |
2008 |
J. Biol. Chem. |
pmid:18534982
|
Sheinin A et al. |
Endocannabinoid- and mGluR5-dependent short-term synaptic depression in an isolated neuron/bouton preparation from the hippocampal CA1 region. |
2008 |
J. Neurophysiol. |
pmid:18497350
|
Pertwee RG |
Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond. |
2008 |
Addict Biol |
pmid:18482430
|
Di Marzo V |
Endocannabinoids: synthesis and degradation. |
2008 |
Rev. Physiol. Biochem. Pharmacol. |
pmid:18481028
|
Nomura DK et al. |
Activation of the endocannabinoid system by organophosphorus nerve agents. |
2008 |
Nat. Chem. Biol. |
pmid:18438404
|
Bisogno T |
Endogenous cannabinoids: structure and metabolism. |
2008 |
J. Neuroendocrinol. |
pmid:18426492
|
Richardson D et al. |
Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis. |
2008 |
Arthritis Res. Ther. |
pmid:18416822
|
Solinas M et al. |
The endocannabinoid system in brain reward processes. |
2008 |
Br. J. Pharmacol. |
pmid:18414385
|
Di Marzo V and Maccarrone M |
FAAH and anandamide: is 2-AG really the odd one out? |
2008 |
Trends Pharmacol. Sci. |
pmid:18394720
|
Awumey EM et al. |
Cytochrome P-450 metabolites of 2-arachidonoylglycerol play a role in Ca2+-induced relaxation of rat mesenteric arteries. |
2008 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:18375719
|
Rubio M et al. |
CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats. |
2008 |
Neuropharmacology |
pmid:18371990
|
Engeli S et al. |
Peripheral endocannabinoid system activity in patients treated with sibutramine. |
2008 |
Obesity (Silver Spring) |
pmid:18356837
|
Palkovits M et al. |
Regional distribution and effects of postmortal delay on endocannabinoid content of the human brain. |
2008 |
Neuroscience |
pmid:18343585
|
Vellani V et al. |
Functional lipidomics. Calcium-independent activation of endocannabinoid/endovanilloid lipid signalling in sensory neurons by protein kinases C and A and thrombin. |
2008 |
Neuropharmacology |
pmid:18329052
|
Jeong WI et al. |
Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver. |
2008 |
Cell Metab. |
pmid:18316028
|
Friedman SL and Nieto N |
Cannabinoids provoke alcoholic steatosis through a conspiracy of neighbors. |
2008 |
Cell Metab. |
pmid:18316020
|
Hill MN et al. |
Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report. |
2008 |
Pharmacopsychiatry |
pmid:18311684
|
Oláh M et al. |
The role of endocannabinoids in the regulation of luteinizing hormone and prolactin release. Differences between the effects of AEA and 2AG. |
2008 |
Mol. Cell. Endocrinol. |
pmid:18308464
|
Hu SS et al. |
Prostaglandin E2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NFkappaB activity. |
2008 |
Br. J. Pharmacol. |
pmid:18297109
|
Guindon J and Hohmann AG |
A physiological role for endocannabinoid-derived products of cyclooxygenase-2-mediated oxidative metabolism. |
2008 |
Br. J. Pharmacol. |
pmid:18297102
|
Starowicz KM et al. |
Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet. |
2008 |
Obesity (Silver Spring) |
pmid:18239598
|
Shimizu T and Yokotani K |
Bidirectional roles of the brain 2-arachidonoyl-sn-glycerol in the centrally administered vasopressin-induced adrenomedullary outflow in rats. |
2008 |
Eur. J. Pharmacol. |
pmid:18234185
|
Maccarrone M et al. |
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. |
2008 |
Nat. Neurosci. |
pmid:18204441
|
King AR et al. |
URB602 inhibits monoacylglycerol lipase and selectively blocks 2-arachidonoylglycerol degradation in intact brain slices. |
2007 |
Chem. Biol. |
pmid:18096504
|
Blankman JL et al. |
A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. |
2007 |
Chem. Biol. |
pmid:18096503
|
Imming P |
Fatty pain cures. |
2007 |
Chem. Biol. |
pmid:18096498
|
Marrs W and Stella N |
2-AG + 2 new players = forecast for therapeutic advances. |
2007 |
Chem. Biol. |
pmid:18096497
|
Adermark L and Lovinger DM |
Retrograde endocannabinoid signaling at striatal synapses requires a regulated postsynaptic release step. |
2007 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:18077376
|
Hill MN et al. |
Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus. |
2008 |
Hippocampus |
pmid:18058925
|
Béquet F et al. |
CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus. |
2007 |
Eur. J. Neurosci. |
pmid:18052990
|
Thiemann G et al. |
The role of the CB1 cannabinoid receptor and its endogenous ligands, anandamide and 2-arachidonoylglycerol, in amphetamine-induced behavioural sensitization. |
2008 |
Behav. Brain Res. |
pmid:17988751
|
Muccioli GG and Stella N |
An optimized GC-MS method detects nanomolar amounts of anandamide in mouse brain. |
2008 |
Anal. Biochem. |
pmid:17981259
|
Dainese E et al. |
Modulation of the endocannabinoid system by lipid rafts. |
2007 |
Curr. Med. Chem. |
pmid:17979719
|
Mukhopadhyay S and Tulis DA |
Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke. |
2007 |
Cardiovasc Hematol Agents Med Chem |
pmid:17979695
|
Rimmerman N et al. |
Compartmentalization of endocannabinoids into lipid rafts in a dorsal root ganglion cell line. |
2008 |
Br. J. Pharmacol. |
pmid:17965731
|
Tanikawa T et al. |
Induction of preferential chemotaxis of unstimulated B-lymphocytes by 2-arachidonoylglycerol in immunized mice. |
2007 |
Microbiol. Immunol. |
pmid:17951991
|
Shiratsuchi A et al. |
Involvement of cannabinoid receptor CB2 in dectin-1-mediated macrophage phagocytosis. |
2008 |
Immunol. Cell Biol. |
pmid:17909562
|
Opitz CA et al. |
Production of the endocannabinoids anandamide and 2-arachidonoylglycerol by endothelial progenitor cells. |
2007 |
FEBS Lett. |
pmid:17904123
|
Hillard CJ et al. |
Inhibition of 2-arachidonoylglycerol catabolism modulates vasoconstriction of rat middle cerebral artery by the thromboxane mimetic, U-46619. |
2007 |
Br. J. Pharmacol. |
pmid:17891162
|
Duan Y et al. |
Inhibition of [3H]batrachotoxinin A-20alpha-benzoate binding to sodium channels and sodium channel function by endocannabinoids. |
2008 |
Neurochem. Int. |
pmid:17888543
|
Sakamoto Y et al. |
Clinical responses and improvement of some laboratory parameters following polymyxin B-immobilized fiber treatment in septic shock. |
2007 Sep-Oct |
ASAIO J. |
pmid:17885340
|
Ryberg E et al. |
The orphan receptor GPR55 is a novel cannabinoid receptor. |
2007 |
Br. J. Pharmacol. |
pmid:17876302
|
Degn M et al. |
Changes in brain levels of N-acylethanolamines and 2-arachidonoylglycerol in focal cerebral ischemia in mice. |
2007 |
J. Neurochem. |
pmid:17868306
|
Vadivel SK et al. |
Conformationally constrained analogues of 2-arachidonoylglycerol. |
2007 |
Bioorg. Med. Chem. Lett. |
pmid:17826996
|
Cisneros JA et al. |
Structure-activity relationship of a series of inhibitors of monoacylglycerol hydrolysis--comparison with effects upon fatty acid amide hydrolase. |
2007 |
J. Med. Chem. |
pmid:17764163
|
Sugiura T |
[2-Arachidonoylglycerol: an endogenous cannabinoid receptor ligand]. |
2007 |
Seikagaku |
pmid:17763698
|
Saario SM and Laitinen JT |
Monoglyceride lipase as an enzyme hydrolyzing 2-arachidonoylglycerol. |
2007 |
Chem. Biodivers. |
pmid:17712832
|
Moreira FA et al. |
Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. |
2008 |
Neuropharmacology |
pmid:17709120
|
Smid SD et al. |
The endocannabinoids anandamide and 2-arachidonoylglycerol inhibit cholinergic contractility in the human colon. |
2007 |
Eur. J. Pharmacol. |
pmid:17706636
|
Chiu CQ and Castillo PE |
Input-specific plasticity at excitatory synapses mediated by endocannabinoids in the dentate gyrus. |
2008 |
Neuropharmacology |
pmid:17706254
|
Tam J et al. |
The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling. |
2008 |
FASEB J. |
pmid:17704191
|
He F et al. |
Involvement of the 90-kDa heat shock protein (Hsp-90) in CB2 cannabinoid receptor-mediated cell migration: a new role of Hsp-90 in migration signaling of a G protein-coupled receptor. |
2007 |
Mol. Pharmacol. |
pmid:17698952
|
Lafourcade M et al. |
Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex. |
2007 |
PLoS ONE |
pmid:17684555
|
Mátyás F et al. |
Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area. |
2008 |
Neuropharmacology |
pmid:17655884
|
Hashimotodani Y et al. |
Pharmacological evidence for the involvement of diacylglycerol lipase in depolarization-induced endocanabinoid release. |
2008 |
Neuropharmacology |
pmid:17655882
|
Centonze D et al. |
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. |
2007 |
Brain |
pmid:17626034
|
Gokoh M et al. |
2-Arachidonoylglycerol enhances the phagocytosis of opsonized zymosan by HL-60 cells differentiated into macrophage-like cells. |
2007 |
Biol. Pharm. Bull. |
pmid:17603153
|
Williams J et al. |
Quantitative method for the profiling of the endocannabinoid metabolome by LC-atmospheric pressure chemical ionization-MS. |
2007 |
Anal. Chem. |
pmid:17600384
|
Fan SF and Yazulla S |
Retrograde endocannabinoid inhibition of goldfish retinal cones is mediated by 2-arachidonoyl glycerol. |
2007 May-Jun |
Vis. Neurosci. |
pmid:17592669
|
Jung KM et al. |
A key role for diacylglycerol lipase-alpha in metabotropic glutamate receptor-dependent endocannabinoid mobilization. |
2007 |
Mol. Pharmacol. |
pmid:17584991
|
Labar G et al. |
Disulfiram is an inhibitor of human purified monoacylglycerol lipase, the enzyme regulating 2-arachidonoylglycerol signaling. |
2007 |
Chembiochem |
pmid:17579916
|
Rubio M et al. |
Short-term exposure to alcohol in rats affects brain levels of anandamide, other N-acylethanolamines and 2-arachidonoyl-glycerol. |
2007 |
Neurosci. Lett. |
pmid:17574742
|
Karsak M et al. |
Attenuation of allergic contact dermatitis through the endocannabinoid system. |
2007 |
Science |
pmid:17556587
|
Soria-Gómez E et al. |
Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus. |
2007 |
Br. J. Pharmacol. |
pmid:17549045
|
Sang N et al. |
COX-2 oxidative metabolite of endocannabinoid 2-AG enhances excitatory glutamatergic synaptic transmission and induces neurotoxicity. |
2007 |
J. Neurochem. |
pmid:17539917
|
Ortar G et al. |
Carbamoyl tetrazoles as inhibitors of endocannabinoid inactivation: a critical revisitation. |
2008 |
Eur J Med Chem |
pmid:17452063
|
Endsley MP et al. |
Diverse roles of 2-arachidonoylglycerol in invasion of prostate carcinoma cells: Location, hydrolysis and 12-lipoxygenase metabolism. |
2007 |
Int. J. Cancer |
pmid:17443494
|
Siegmund SV et al. |
The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species. |
2007 |
FASEB J. |
pmid:17440119
|
Gonthier MP et al. |
Identification of endocannabinoids and related compounds in human fat cells. |
2007 |
Obesity (Silver Spring) |
pmid:17426318
|
Ryan D et al. |
Interactions of cannabidiol with endocannabinoid signalling in hippocampal tissue. |
2007 |
Eur. J. Neurosci. |
pmid:17419758
|
Uchigashima M et al. |
Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. |
2007 |
J. Neurosci. |
pmid:17409230
|
D'Argenio G et al. |
Overactivity of the intestinal endocannabinoid system in celiac disease and in methotrexate-treated rats. |
2007 |
J. Mol. Med. |
pmid:17396241
|
Muccioli GG et al. |
Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells. |
2007 |
J. Neurosci. |
pmid:17360910
|
Basavarajappa BS |
Critical enzymes involved in endocannabinoid metabolism. |
2007 |
Protein Pept. Lett. |
pmid:17346227
|
Oka S et al. |
Depolarization-induced rapid generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in rat brain synaptosomes. |
2007 |
J. Biochem. |
pmid:17339228
|
Ade KK and Lovinger DM |
Anandamide regulates postnatal development of long-term synaptic plasticity in the rat dorsolateral striatum. |
2007 |
J. Neurosci. |
pmid:17329438
|
DeMorrow S et al. |
Opposing actions of endocannabinoids on cholangiocarcinoma growth: recruitment of Fas and Fas ligand to lipid rafts. |
2007 |
J. Biol. Chem. |
pmid:17329257
|
Bátkai S et al. |
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury. |
2007 |
FASEB J. |
pmid:17327359
|
Hohmann AG |
Inhibitors of monoacylglycerol lipase as novel analgesics. |
2007 |
Br. J. Pharmacol. |
pmid:17293886
|
Coopman K et al. |
Temporal variation in CB2R levels following T lymphocyte activation: evidence that cannabinoids modulate CXCL12-induced chemotaxis. |
2007 |
Int. Immunopharmacol. |
pmid:17276894
|
Wang H et al. |
Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation. |
2007 |
Prostaglandins Other Lipid Mediat. |
pmid:17259073
|
Palomäki VA et al. |
Visualization of 2-arachidonoylglycerol accumulation and cannabinoid CB1 receptor activity in rat brain cryosections by functional autoradiography. |
2007 |
J. Neurochem. |
pmid:17254014
|